» Articles » PMID: 12046069

Effects of Epidermal Growth Factor on the Growth of Human Gastric Cancer Cell and the Implanted Tumor of Nude Mice

Overview
Specialty Gastroenterology
Date 2002 Jun 5
PMID 12046069
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Epidermal growth factor (EGF) plays an important role in the regulation of gastrointestinal tissue growth and development, and it can stimulate epithelial proliferation, cell differentiation and growth. It has been established that the EGF can promote gastric cytoprotection and ulcer healing. But the potential ability of EGF to regulate the gastric cancer growth is unknown. This study is to investigate the influence of EGF on human gastric cancer cell and the implanted tumor growth of nude mice.

Methods: The cell growth rates of human gastric adenocarcinoma cell lines MKN-28, MKN-45, SGC-7901 and normal human gastric epithelial cells 3T3 were assessed when incubated with recombinant human EGF (rhEGF, 0.05, 0.1, 0.5, 1.0, 10, 50, 100 mg.L(-1)) using MTT method. The cells of MKN-28, MKN-45, SGC-7901 (gastric cancer tissue 1.5mm(3)) were implanted in the BALB/cA nude mice for 10 days. The EGF was given intraperitoneally (15, 30, 60 microg.kg(-1)) for 3 weeks. The body weights of the tumor-bearing animals and their tumor mass were measured afterwards to assess the mitogenic effect of rhEGF in the nude mice.

Results: Within the concentration range of 0.05-100mg.L(-1), rhEGF could increase the cell growth of normal 3T3 cells (cell growth rate 100% vs 102.8%, P<0.05), but partially restrain the gastric cancer cell growth. The latter effect was related to cell differentiation. In 15-60 microg/kg rhEGF groups, the mean implanted tumor mass of MKN-28 cell were 1.75 g, 1.91 g, 2.08 g/NS group 1.97 g (P>0.05), the mean tumor mass of SGC-7901 cell were 1.53 g, 1.07 g, 1.20 g/NS group 1.07 g (P>0.05), and for MKN-45 cell, the tumor mass were respectively 1.92 g, 1.29 g, 1.77 /NS group 1.82 g (P>0.05). So rhEGF had no obvious effect on implanted MKN-28, SGC-7901 and MKN-45 tumor growth.

Conclusion: EGF has no stimulating effect on the human gastric cancer cell growth neither in vitro nor in vivo.

Citing Articles

Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Berlanga-Acosta J, Gavilondo-Cowley J, Lopez-Saura P, Gonzalez-Lopez T, Castro-Santana M, Lopez-Mola E Int Wound J. 2009; 6(5):331-46.

PMID: 19912390 PMC: 7951530. DOI: 10.1111/j.1742-481X.2009.00622.x.


Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.

Hong J, Lee S, Song S, Ahn S, Shin S, Choi E Eur J Cancer Care (Engl). 2009; 18(6):636-41.

PMID: 19456848 PMC: 2776929. DOI: 10.1111/j.1365-2354.2008.00971.x.


Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Liu S, Dong W, Wu D, Luo H, Yu J World J Gastroenterol. 2003; 9(12):2786-90.

PMID: 14669334 PMC: 4612053. DOI: 10.3748/wjg.v9.i12.2786.


Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer.

Zhang X, Wang X, Sheng S, Wang J, Li J World J Gastroenterol. 2003; 9(8):1729-33.

PMID: 12918109 PMC: 4611532. DOI: 10.3748/wjg.v9.i8.1729.


Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.

Du J, Dou K, Peng S, Qian B, Xiao H, Liu F World J Gastroenterol. 2003; 9(7):1431-4.

PMID: 12854135 PMC: 4615477. DOI: 10.3748/wjg.v9.i7.1431.


References
1.
Ross J, McKenna B . The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest. 2001; 19(5):554-68. DOI: 10.1081/cnv-100103852. View

2.
Becker K, Keller G, Hoefler H . The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol. 2001; 9(1):5-11. DOI: 10.1016/s0960-7404(00)00016-5. View

3.
Konturek J, Hengst K, Konturek S, Domschke W . Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative. Scand J Gastroenterol. 1997; 32(10):980-4. DOI: 10.3109/00365529709011213. View

4.
Arakawa T, Watanabe T, Fukuda T, Higuchi K, Takaishi O, Yamasaki K . Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence. Possible mediation of prostaglandins. Dig Dis Sci. 1996; 41(10):2055-61. DOI: 10.1007/BF02093610. View

5.
Koyama S, Maruyama T, Adachi S . Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. J Cancer Res Clin Oncol. 1999; 125(1):47-54. DOI: 10.1007/s004320050241. View